ERBB4 and breast cancer: To achieve greater clinical value and utility of HER4 in breast cancer, more detailed identification of the expression and localization of HER4 isoforms should be initiated and validated in a broader cohort of patients with breast cancer, which would provide a much larger sample size and would be more informative.